ALLOGENE THERAPEUTICS INC (ALLO) Stock Earnings Estimates
NASDAQ:ALLO • US0197701065
2.08 USD
+0.03 (+1.46%)
At close: Feb 23, 2026
2.0869 USD
+0.01 (+0.33%)
After Hours: 2/23/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 240K -99.38% | 95K -60.42% | 22K -76.84% | -100.00% | 18.544K | 26.203M 141,204.82% | 163.62M 524.43% | 346.98M 112.06% | 658.87M 89.89% | 916.69M 39.13% | 1.203B 31.23% | 1.468B 22.03% | |
| EBITDA YoY % growth | -321.15M -30.90% | -300.293M 6.49% | -243.843M 18.80% | -210.633M 13.62% | -212.546M -0.91% | -270.107M -27.08% | -290.639M -7.60% | -219.188M 24.58% | -63.668M 70.95% | N/A | N/A | N/A | |
| EBIT YoY % growth | -335.45M -31.14% | -314.492M 6.25% | -257.482M 18.13% | -222.769M 13.48% | -224.183M -0.63% | -235.786M -5.18% | -201.715M 14.45% | -21.571M 89.31% | 235.1M 1,189.89% | 405.03M 72.28% | 617.91M 52.56% | 808.51M 30.85% | |
| Operating Margin | -139,770.83% | -331,044.21% | -1,170,372.73% | N/A | -1,208,949.01% | -899.84% | -123.28% | -6.22% | 35.68% | 44.18% | 51.36% | 55.08% | |
| EPS YoY % growth | -2.32 -22.75% | -2.01 13.36% | -1.33 33.83% | -0.96 27.78% | -0.89 6.89% | -0.84 6.35% | -0.72 13.95% | 0.09 112.27% | 1.36 1,441.75% | 2.21 61.97% | 3.29 48.96% | 4.39 33.33% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.22 22.07% | -0.22 23.14% | -0.22 2.73% | -0.23 -18.64% | -0.23 -4.38% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -48.849M -4.26% | -50.697M 18.35% | -53.992M -11.94% | -57.891M -62.62% | N/A |
| EBIT Q2Q % growth | -54.103M 10.56% | -53.533M 17.88% | -56.095M -3.05% | -58.104M -29.41% | -61.215M -13.14% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.19 40.63% | -0.23 | 0.04 | 16.55% |
| Q2 2025 Q2Q % growth | -0.23 34.29% | -0.28 | 0.05 | 17.55% |
| Q1 2025 Q2Q % growth | -0.28 26.32% | -0.30 | 0.02 | 5.26% |
| Q4 2024 Q2Q % growth | -0.28 34.88% | -0.34 | 0.06 | 17.64% |
| Q3 2024 Q2Q % growth | -0.32 13.51% | -0.34 | 0.02 | 4.75% |
| Q2 2024 Q2Q % growth | -0.35 33.96% | -0.35 | 0.00 | 1.21% |
| Q1 2024 Q2Q % growth | -0.38 44.12% | -0.42 | 0.04 | 8.99% |
| Q4 2023 Q2Q % growth | -0.43 34.85% | -0.46 | 0.03 | 6.14% |
| Q3 2023 Q2Q % growth | -0.37 36.21% | -0.53 | 0.16 | 30.17% |
| Q2 2023 Q2Q % growth | -0.53 -1.92% | -0.60 | 0.07 | 11.77% |
| Q1 2023 Q2Q % growth | -0.68 -21.43% | -0.63 | -0.05 | -8.03% |
| Q4 2022 Q2Q % growth | -0.66 -22.22% | -0.71 | 0.05 | 7.43% |
| Q3 2022 Q2Q % growth | -0.58 -1.75% | -0.66 | 0.08 | 11.76% |
| Q2 2022 Q2Q % growth | -0.52 1.89% | -0.62 | 0.10 | 16.43% |
| Q1 2022 Q2Q % growth | -0.56 -124.00% | -0.59 | 0.03 | 4.62% |
| Q4 2021 Q2Q % growth | -0.54 -1.89% | -0.61 | 0.07 | 11.52% |
| Q3 2021 Q2Q % growth | -0.57 -9.62% | -0.57 | 0.00 | 0.01% |
| Q2 2021 Q2Q % growth | -0.53 | -0.56 | 0.03 | 4.97% |
| Q1 2021 Q2Q % growth | -0.25 50.00% | -0.46 | 0.21 | 46.19% |
| Q4 2020 Q2Q % growth | -0.53 | -0.57 | 0.04 | 6.80% |
| Q3 2020 Q2Q % growth | -0.52 | -0.55 | 0.03 | 5.21% |
| Q2 2020 Q2Q % growth | -0.53 | -0.55 | 0.02 | 4.01% |
| Q1 2020 Q2Q % growth | -0.50 | -0.59 | 0.09 | 15.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.856K | -1.856K | -100.00% | |
| Q1 2025 Q2Q % growth | -100.00% | 1.856K | -1.856K | -100.00% |
| Q4 2024 Q2Q % growth | -100.00% | 14.28K | -14.28K | -100.00% |
| Q3 2024 Q2Q % growth | -100.00% | 13.189K | -13.189K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 17.248K | -17.248K | -100.00% |
| Q1 2024 Q2Q % growth | 22K -57.69% | 9.792K | 12.208K | 124.67% |
| Q4 2023 Q2Q % growth | 21K -58.00% | 24.041K | -3.041K | -12.65% |
| Q3 2023 Q2Q % growth | 43K -14.00% | 12.781K | 30.219K | 236.45% |
| Q2 2023 Q2Q % growth | 44K -51.11% | 19.268K | 24.732K | 128.36% |
| Q1 2023 Q2Q % growth | 52K -13.33% | 10.914K | 41.086K | 376.45% |
| Q4 2022 Q2Q % growth | 50K | 61.404K | -11.404K | -18.57% |
| Q3 2022 Q2Q % growth | 50K | 14.912K | 35.088K | 235.29% |
| Q2 2022 Q2Q % growth | 90K 125.00% | 5.661K | 84.339K | 1,489.83% |
| Q1 2022 Q2Q % growth | 60K -99.84% | 60K | % | |
| Q4 2021 Q2Q % growth | 50K | -6.324K | 56.324K | 890.64% |
| Q3 2021 Q2Q % growth | 50K | 14.576K | 35.424K | 243.03% |
| Q2 2021 Q2Q % growth | 40K | 235.814K | -195.814K | -83.04% |
| Q1 2021 Q2Q % growth | 38.35M | 13.102M | 25.248M | 192.70% |
| Q4 2020 Q2Q % growth | 3.23M | -3.23M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.33% | -0.73% | 4.6% |
| Revenue | N/A | N/A | N/A | -100% |